|
|
Volumn 9, Issue 3, 2001, Pages 209-210
|
|
Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin b in cancer patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
FLUCONAZOLE;
LIPOSOME;
NYSTATIN;
ADULT;
CANCER PATIENT;
CASE REPORT;
DRUG CHOICE;
DRUG EFFICACY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
LUNG ASPERGILLOSIS;
MALE;
NEPHROTOXICITY;
PRIORITY JOURNAL;
SCHOOL CHILD;
ADOLESCENT;
ADULT;
AMPHOTERICIN B;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
CHILD;
FEMALE;
FLUCONAZOLE;
HUMANS;
LIPOSOMES;
LUNG DISEASES, FUNGAL;
MALE;
MIDDLE AGED;
NEOPLASMS;
NYSTATIN;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0035036677
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s005200000194 Document Type: Letter |
|
Times cited : (11)
|
|
References (5)
|
